statistiche ricercatore

Continente	#
NA - Nord America	473
AS - Asia	343
EU - Europa	323
SA - Sud America	96
Continente sconosciuto - Info sul continente non disponibili	42
AF - Africa	14
OC - Oceania	2
Totale	1.293

Nazione	#
US - Stati Uniti d'America	452
IT - Italia	159
SG - Singapore	121
BR - Brasile	79
CN - Cina	75
HK - Hong Kong	44
RU - Federazione Russa	34
DE - Germania	25
VN - Vietnam	24
GB - Regno Unito	23
IN - India	20
FR - Francia	17
SE - Svezia	17
CA - Canada	12
FI - Finlandia	12
BD - Bangladesh	11
JP - Giappone	9
AR - Argentina	7
ID - Indonesia	7
PL - Polonia	6
HU - Ungheria	5
AT - Austria	4
IL - Israele	4
NL - Olanda	4
UZ - Uzbekistan	4
ZA - Sudafrica	4
AE - Emirati Arabi Uniti	3
CI - Costa d'Avorio	3
CZ - Repubblica Ceca	3
EC - Ecuador	3
ES - Italia	3
MX - Messico	3
NO - Norvegia	3
PK - Pakistan	3
AU - Australia	2
AZ - Azerbaigian	2
BE - Belgio	2
CO - Colombia	2
IQ - Iraq	2
IR - Iran	2
JM - Giamaica	2
KR - Corea	2
LT - Lituania	2
MD - Moldavia	2
PH - Filippine	2
SA - Arabia Saudita	2
SN - Senegal	2
TR - Turchia	2
UY - Uruguay	2
CL - Cile	1
CR - Costa Rica	1
DZ - Algeria	1
EG - Egitto	1
GT - Guatemala	1
IE - Irlanda	1
KE - Kenya	1
KZ - Kazakistan	1
LB - Libano	1
MA - Marocco	1
ML - Mali	1
NP - Nepal	1
PA - Panama	1
PR - Porto Rico	1
PY - Paraguay	1
SI - Slovenia	1
SR - Suriname	1
TH - Thailandia	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.252

Nome	#
Harmaline-based scaffold as Human Caseinolytic Protease P (hClpP) inducers for Diffuse Intrinsic Pontine Glioma (DIPG) treatment	178
A further pocket or conformational plasticity by mapping COX-1 catalytic site through modified-mofezolac structure-inhibitory activity relationships and their antiplatelet behavior	143
Cyclooxygenase-1 Inhibition: A Promising Theragnostic Approach for Ovarian Cancer	130
Molecular simplification of natural products: Synthesis, antibacterial activity, and molecular docking studies of berberine open models	130
Fluorescent imaging probes for in vivo ovarian cancer targeted detection and surgery	118
Fluorochrome Selection for Imaging Intraoperative Ovarian Cancer Probes	102
Repurposing of natural origin compounds as HsClpP inducers to treat diffuse midline glioma (DMG)	96
COX-1 INHIBITORS AS ANTI-PLATELET AGENTS IN COVID-19	94
Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment	94
CHALLENGE TRANSABILITY OF “IN VITRO” TO “IN VIVO”: GENE-EXPRESSION BIOMARKERS AND FLUORESCENT IMAGE-GUIDED SURGERY PROBES IDENTIFICATION FOR OVARIAN CANCER	94
DIPG-27. Diffuse Intrinsic Pontine Glioma (DIPG) challenge: from gene expression profile to drug.	86
Therapeutic Role of Cyclooxygenase-1 (COX-1) Inhibition, Challenging the Conventional View of COX-1 as Purely Constitutive	28
Totale	1.293

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	5	0	0	0	0	0	1	0	0	1	1	1	1
2022/2023	31	2	3	1	1	4	3	1	9	6	1	0	0
2023/2024	140	1	4	5	7	5	5	1	1	82	16	1	12
2024/2025	313	16	6	9	12	21	19	57	36	23	29	27	58
2025/2026	707	88	31	41	75	71	39	74	29	86	80	46	47
2026/2027	90	47	23	20	0	0	0	0	0	0	0	0	0
Totale													1.293